Evaluation of Outcomes and Complications of Arteriovenous Fistulas for Haemodialysis Access in Paediatric Patients with Chronic Kidney Disease. by Nupur, Bit
Evaluation of Outcomes and Complications of 
Arteriovenous Fistulas for Haemodialysis Access in 
Paediatric Patients with Chronic Kidney Disease 
 
Dissertation submitted for the degree for 
the partial fulfilment of the 
regulations for the award of the degree of 
 
M.Ch Vascular Surgery 
Branch VIII 
AUGUST-2013 
 
 
 
THE TAMIL NADU DR.M.G.R. MEDICAL UNIVERSITY 
CHENNAI, 
TAMILNADU 
 
 
 
 
CERTIFICATE 
 
 
 
This is to certify that this dissertation entitled “Evaluation of outcomes and 
complications of arteriovenous fistulas for haemodialysis access in 
paediatric patients with chronic kidney disease” is a bonafide record of the 
research work done by Dr. Nupur Bit, for the award of  M.Ch., Vascular 
Surgery, under the supervision of  Prof. T. Vidyasagaran MS, DNB, MCH, 
Professor & Head, Department of Vascular Surgery, Rajiv Gandhi Government 
General Hospital, Madras Medical College, Chennai. I also certify that this 
dissertation is the result of the independent work done by the candidate. 
 
 
 
 
 
Prof.KANAGASABAI, M.D. 
DEAN 
MADRAS MEDICAL COLLEGE 
&GOVT. GENERAL HOSPITAL, 
CHENNAI – 600 003. 
 PROF.T.VIDYASAGRAN 
  M.S, DNB, M.Ch  
PROFESSOR & H.O.D, 
DEPT OF VASCULAR SURGERY, 
MADRAS MEDICAL COLLEGE, 
CHENNAI – 600 003. 
 
 
 
                            
DECLARATION 
I solemnly declare that this dissertation  
           “Evaluation of outcomes and complications of arteriovenous fistulas 
for haemodialysis access in paediatric patients with chronic kidney 
disease.” 
was prepared by me in the Department of Vascular Surgery, Rajiv Gandhi 
Government General Hospital, Madras Medical College, Chennai under the 
guidance and supervision of Prof. T.Vidyasagaran, MS, DNB, M.Ch., 
Professor & Head of the Department, Department of Vascular Surgery, Rajiv 
Gandhi Government General Hospital, Madras Medical College, Chennai. This 
dissertation is submitted to the Tamil Nadu Dr. M.G.R. Medical University, 
Chennai in partial fulfilment of the University requirements for the award of the 
degree of M.Ch. Vascular Surgery. 
 
 
Nupur Bit 
Place : Chennai 
Date : 9
th
 March 2013 
 
 ACKNOWLEDGEMENTS 
 
 
I am extremely thankful to Dr. Kanagasabai, Dean, Madras Medical 
College, for his kind permission to carry out this study. 
I hereby wish to express my gratitude to Prof T.Vidyasagaran, HOD, 
Department of Vascular Surgery for his guidance and experience  in 
formulation of this dissertation. 
I would also like to acknowledge the valuable support provided by 
Prof. J.Amalorpavanathan, Unit Chief, Dept of Vascular Surgery, Madras 
Medical College. I am indebted to my co-guide Dr. N.Sritharan, and other 
assistant professors  Dr. Ilayakumar. P, Dr. Bhaktavatchalam, Dr. 
Balakumar, Dr. K.Elancheralathan and Dr. Velladuraichi  who have 
constantly guided me in the compilation of this dissertation. 
I extend my thanks to all staff members in the Dept. of Vascular Surgery, 
Madras Medical College and Govt. General Hospital, Chennai for their support. 
Last but not the least, I thank the patients and their parents who have willingly 
participated in this study and despite their ailments, placed their faith in us. 
 
Nupur Bit 
 
 
CONTENTS 
1. Keywords 
2. Review of literature 
a. Introduction 
b. Considerations in children 
c. Techniques in paediatric AV access creation 
d. Monitoring and surveillance of AVF 
e. Statistics from USA 
f. Literature from elsewhere in the world 
g. Literature from India 
h. Paediatric renal transplantation – trends and outcome 
3. Materials and methods 
4. Results 
5. Discussion 
6. Conclusions 
7. Implications 
8. Annexure 
a. Bibliography 
b. Anti-plagiarism certificate 
c. Ethical committee certificate 
 
 
 
  
Key words: 
End-stage renal disease (ESRD) 
Acute kidney injury (AKI) 
Acute renal failure (ARF) 
Renal Replacement Therapy (RRT) 
Cuffed Venous Catheter (CVC) 
Arteriovenous access (AV access) 
Arteriovenous fistula (AVF) 
Arteriovenous graft (AVG) 
Chronic renal failure (CRF) 
Vascular access (VA) 
Radiocephalic fistula (RC-F) 
Brachiocephalic fistula (BC-F) 
Brachiobasilic transposition (BBT) 
Renal transplantation (RTx) 
Primary failure rate 
Primary patency rare 
Secondary patency rate 
Peritoneal dialysis (PD) 
Haemodialysis (HD) 
 
  
 
 
Review of literature  
  
Introduction: 
Haemodialysis for long term became a possibility as a treatment option in 
chronic renal failure (CRF) in 1960 after Quinton and Scribner devised an 
external shunt that provided repetitive access to the circulation. The first 
arteriovenous (AV) access procedure was described by Brescia and Cimino in 
1966.(1) Subsequently the development of various access techniques and 
devices occurred and today renal failure patients can survive on HD for 
decades. 
An ideal vascular access (VA) system should have the following features: 
1. Reliable, repetitive access to the circulation 
2. Flow rates sufficient to deliver efficient dialysis 
3. Prolonged patency 
4. Low complication rate 
However, no known method has been able to reach the ‘ideal’ situation. 
Haemodialysis access failure is today the commonest cause of hospitalization 
and is responsible for the highest number of hospitalised days for the patients on 
haemodialysis. 
Types of vascular access (VA): 
1. Placement of a temporary or permanent double lumen central venous 
catheter (CVC) 
2. Creation of an autogenous arteriovenous (AV) access (native or natural 
fistula) 
3. Placement of a nonautogenous AV access (bridge AV graft) 
Most appropriate access option for a particular patient depends on several 
factors, such as: 
1. Age 
2. Comorbid states 
3. Vascular anatomy 
4. Previous access procedures 
5. Timing of haemodialysis 
Site selection: 
Silva et al have recommended that a superficial vein diameter exceeding 2.5mm 
without segmental sclerosis, stenosis or occlusion should be selected for 
optimum results. The non-dominant arm and distal fistulas should be given 
preference. 
Nomenclature: (SVS/ American Association for Vascular Surgery (AAVS) 
Reporting Standards for Vascular Accesses) 
1. Autogenous AV access – An access created by a connection between an 
artery and a vein whereby the vein serves as an accessible conduit.  
2. Nonautogenous AV access – An access created by connecting an artery to 
a vein with a graft. This may be prosthetic (eg, polytetrafluoroethylene, 
polyurethane or Dacron) or biograft (eg, bovine heterograft or human 
umbilical vein). 
3. Primary patency – The interval from the time of access placement until 
any intervention designed to maintain or re-establish patency or 
functionality. 
4. Assisted primary patency – The interval from the time of access 
placement until access thrombosis, including intervening manipulations, 
such as balloon angioplasty, designed to maintain the functionality of a 
patent access. 
5. Secondary patency – The interval from the time of access placement until 
access abandonment, including intervening manipulations, such as 
thrombectomy, designed to re-establish functionality in thrombosed 
access. 
Outcome of Autogenous vs Nonautogenous AV Access procedures: 
The primary failure rates for AVFs in adults, has been reported to be 8-40%.The 
1-year primary patency rates for AVFs and AVGs in adults is in the range of 
40-60% and 1-year secondary patency rates for AVFs is 52-80% while for  
AVGs, it is 54-83%. 
Possible factors adversely influencing the maturation of autogenous AV access: 
1. Vein size<2.5-3.0mm 
2. Artery size<1.6mm 
3. Diabetes mellitus 
4. Elderly 
5. Surgeon inexperience 
6. African American race 
7. Peripheral vascular disease 
8. Obesity  
9. Female 
10. Previous failed access 
NKF/DOQI guidelines: 
The Centers for Medicare and Medicaid Services and the National Kidney 
Foundation – Kidney Disease Outcomes Quality Initiative emphasized the need 
for increased AVF use in adult haemodialysis patients while also decreasing 
CVC use.(22,3) Specifically, the Centers for Medicare and Medicaid Services 
End-Stage Renal Disease (ESRD) Clinical Performance Measures Project 
defined the objective as: 
A primary AVF should be the access of choice for atleast 50% of all new 
patients while initiating haemodialysis. Also, a native AVF should be the 
primary access for 40% of all prevalent patients undergoing haemodialysis.(4) 
CVC associated morbidity and mortality in adult patients receiving maintenance 
haemodialysis is now well recognized. This has led to an emphasis on creation 
of permanent VA, known as the Fistula First Initiative. The goal of this 
coalition was to achieve the mentioned targets through change in concepts and 
process improvement. 
  
Considerations in children:- 
Vascular access(VA) has been heralded as the backbone to the provision 
of dialysis, and in children this poses unique challenges to the paediatric 
dialysis care provider due to the smaller vessel diameters and vascular 
hyperreactivity. Whether in the face of acute kidney injury (AKI) requiring 
renal replacement therapy (RRT) or as a result of chronic kidney disease 
(CKD), children cannot be considered “little adults”. Further it is imperative to 
provide adequate VA for current RRT requirements without compromising 
future potential access sites. This requires a different surgical philosophy and 
therefore it is important to study the factors which contribute to the success or 
failure of these interventions.  
 Although preemptive renal transplantation (PET) is the preferred RRT for 
paediatric ESRD, in our patient population scenario, it is not always feasible 
due to lack of suitable donors and other logistic considerations. Moreover in the 
subset of patients with peritoneal membrane failure, failed transplants or poor 
social conditions, chronic haemodialysis (HD) remains the only option.  
 Chronic haemodialysis (HD) access can be obtained in children by 
creation of a primary arteriovenous fistula (AVF), placement of an 
arteriovenous synthetic graft (AVG), or use of a cuffed central venous catheter 
(CVC). Deciding which access is best for a particular patient is based on the 
patient’s diagnosis, age and size, likelihood of transplant, procedural risk, and 
probability of long-term patency, surgical expertise, time available before 
starting dialysis. 
 CVCs are cuffed or uncuffed, tunnelled and dual lumen HD cathters 
inserted under fluoroscopic guidance into a central vessel (eg internal jugular 
vein or subclavian vein) often by an interventional radiologist. CVCs serve well 
in smaller children for whom the vessel calibre is too small for a permanent VA. 
However, they are associated with multiple problems like interrupted flow, poor 
position, frequent infection, thrombosis, or occurrence of central venous 
stenosis. Median patency of CVCs has been reported to be in the range of 4 to 
10.6 months. Secondary patency rates have been reported to be 30-60%. 
 Increased use of peritoneal dialysis (PD), shortened time spent on dialysis 
therapy, perceived difficulties creating and using AVFs and AVGs in small 
children and improvement in CVC technology have contributed to the 
increasing use of CVC as permanent HD access in children and adolescents.  
 The choice between PD and HD is often multifactorial and the role of 
available surgical expertise and resources in the dialysis centre is significant in 
this decision. Often, there are other factors involved. Furth et al found more use 
of HD instead of PD in children of African American descent. Family, patient 
and provider preferences all accounted for the difference in choice of therapy by 
race.(22) Similar differences based on ethnic background regarding choice of 
vascular access was also shown by Schoenmaker et al on 2012.(23) 
Factors affecting patency of AV access in children: 
1. Weight > 15kg 
2. Vein calibre 
3. Episodes of hypotension 
4. Vessel thickness 
5. High BP (can cause haematoma) 
6. Age > 15 years     
Other factors studied: 
1. Gender 
2. Ethnicity 
3. Original disease leading to ESRD 
4. Use of steroids 
5. Age at onset of ESRD 
6. Type of access used, date of creation, duration of function 
7. Complications and interventions 
 
   
  
Literature from India: 
Literature from India regarding CKD in the paediatric age group is 
sparse. 
In a report in 2002, Hari et al from AIIMS described their experience 
with HD in 53 children with ARF or CKD. In their patients aged 2-16 years, PD 
was used as the modality for RRT. If the patient was more than 2 years old and 
continued to require dialysis support beyond 2 weeks, HD was initiated. 
Patients younger than 2 years were managed with intermittent PD. In their 53 
patients, the subclavian vein was used for dialysis in 49.3% sessions, femoral 
vein in 38.2% and internal jugular vein in 10.2% sessions. An AVF was used 
for 2.3% sessions. The authors clarify that since most of their patients were 
dialyzed for less than 6 months, they preferred to use temporary CVCs. They 
report rates of infection and thrombosis of the catheters to be 21.7% and 26.1% 
respectively.  
In 2007, K. Elancheralathan as part of his MCh dissertation studied 142 
patients with CKD who underwent VA creation procedures in Madras Medical 
College, Chennai. This included 21 children. Eleven of these procedures failed, 
however, the remaining were lost to follow-up. 
 
  
Methodology: 
The Institutional Review Board at Madras Medical College approved the 
following study. 
Aims: 
A. Primary 
1. To calculate the primary patency rates of AVF/AVGs in children 
2. To discover factors which may predict the patency 
B. Secondary 
1. To study the perioperative complication rate 
Study design: 
Prospective observational study  
Duration: 
Jan 2010 – Jan 2012 
Inclusion criteria: 
All children (upto age 18) with CKD referred to the Department of Vascular 
Surgery for creation of a permanent vascular access were included. 
Exclusion criteria – nil 
Pre-procedure planning:  
History and physical examination including history and scars of previous access 
procedures, and an evaluation of the superficial veins and peripheral arteries. 
Venous duplex for vein mapping if by physical examination the veins were 
equivocal. Venous duplex for deep vein patency if history of current or past 
catheter dialysis. 
Anaesthesia: 
For AVF, young children were either sedated or administered GA if necessary. 
Some older patients were able to tolerate the procedure with local anaesthesia or 
regional anaesthesia (subclavian or axillary block). Regional anaesthesia with 
sensorcaine and lignocaine induces vasodilatation and reduces postoperative 
pain. One dose of antibiotic was given either in the ward on the morning of the 
procedure or during induction of anaesthesia. 
Procedures: 
1. Radiocephalic fistula 
2. Brachiocephalic fistula 
3. Brachiobasilic transposition – single stage 
4. Brachiobasilic transposition – two stage 
5. AV graft – brachial artery to axillary vein 
6. GSV transposition from brachial artery to axillary vein 
Interventions: 
1. Thrombectomy and redo AVF 
2. Pseudoaneurysm ligation 
3. Haematoma evacuation 
Postoperative care: 
To avoid postoperative thrombosis after creation of AV access, careful attention 
was paid to maintaining  systolic blood pressures and avoidance of dehydration 
in the immediate post-operative period. On the discretion of the operating 
surgeon, sometimes an antiplatelet agent was used for a week post-operatively. 
Routine heparin therapy was not used. Antibiotics were given at the discretion 
of the operating surgeon. 
Procedure: 
For radiocephalic, brachiocephalic and transposed basilica vein AVF, an end to 
side vein to artery anastomosis was performed using either 7-o or 8-o 
monofilament (prolene) suture using continuous technique under 3.2x or 3.5x or 
4.0x or no loupe magnification, depending on surgeon preference. Immediate 
postoperative patency was confirmed by the presence of a thrill or a bruit on 
auscultation. Doppler was not routinely done.  
Many children develop vasospasm intraoperatively in the arteries and veins, and 
as such, infiltration of diluted papaverine solution was used intraoperatively at 
the discretion of the operating surgeon. 
Statistics: 
Demographics and complications were analysed using Fischer’s exact test or 
Chi square analysis. Non-parametric data was presented as median and range. 
Factors associated with primary access failure were also analysed using 
Fischer’s exact test or Chi square tests between groups. Differences in mean 
ages and weights were studied using unpaired t test for each access type. Access 
survival was presented as Kaplan Meier survival curves. Primary access failures 
were included in the analysis while determining the actuarial survival of 
functioning access. Correlation of patient age and weight to patency was done 
using Linear regression model.  
All p values are two-sided and p≤0.05 was considered statistically significant. 
Statistical analyses were performed using SPSS version 15.0 (SPSS, Chicago, 
IL, USA). 
  
Results: 
Demographics: 
Over a 5 month period in ICH the following graph shows the use of various 
vascular accesses for haemodialysis. 
  
 
Total number of patients = 74  (males =49: females =25) 
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 Figure 1. Gender distribution 
Total number of procedures =100 
Gender  : males =  66   females =  34 
Mean patient age at time of start of chronic HD – 10.86 years (range –2-18 
years) 
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Mean time for treatment with chronic HD   - 5.78 months 
 
Figure 2. Age distribution 
 
 
Figure 3.  Weight distribution 
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 Figure 4.  Percentage of patients already on dialysis. 
 
 
 
Figure 6.  Primary disease - cause of CKD 
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Figure 7. Percentage of patients who had pre-op duplex 
 
Figure 8.  Primary success rate 
The primary failure rate was 22%. 
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Figure 10. Procedures done by senior/junior surgeons 
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Figure 12. Type and frequency of procedures done 
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Table 4. 
 AVF/AVG Primary failure P value 
N access (N patients) 100 (74) 22  
% male 66 16  0.451 
Primary disease 
unknown % 
32 9 0.315 
N with age < 10 years at 
creation of VA 
17 2 0.263 
N with weight <20kgs at 
creation of VA 
22  2 0.098 
N on dialysis at creation 
of VA 
76  18 0.469 
0
10
20
30
40
50
60
1 2 3 4
Side of procedure(left) 61 13 0.835 
N of  patients with 
previous failed 
procedure 
29 7 0.793 
Age at onset of CKD 
(mean ± SD) 
12.41 ± 2.79 22 0.033 
Mean number of 
months on dialysis 
7.36 ± 6.42 22 0.141 
Use of pre-op duplex 39 8 0.774 
Use of surgical loupes 74 13 0.071 
Experience of surgeon 
(senior) 
86 17 0.182 
Prolene (8/o) 55 9 0.117 
Table 5. Primary result vs age group 
 Figure 14. Primary result vs age group in years 
Table 6. Primary result vs weight of patient 
 Figure 15. Primary result vs weight in kgs 
Table 7. Type of procedure vs weight of patient 
Weight
20 and aboveBelow  20
C
o
u
n
t
70
60
50
40
30
20
10
0
Primary result
Failure
Success
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 Figure 17. Primary result vs side of procedure 
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Figure 18.  Primary result  vs use of magnifying loupes 
Complications: 
1. Seroma / edema    10 
2. Infection    1 
3. Steal symptoms    1 
4. Pseudoaneurysm   1 
5. Bleed, ooze    2 
Additional procedures required: 
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1. Thrombectomy     2 
2. Pseudoaneurysm ligation    1 
 
 
Figure 19. Mortality rate 
Seven patients died due to complications of chronic renal failure. At the time of 
death, all of them had functional fistulas. 
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Patency curves: 
 
Figure 20. Kaplan Meier curve showing cumulative vascular access survival for all procedures 
 
Figure 21 Kaplan Meier curve showing survival rates of fistulas based on the type of procedure 
Discussion: 
Demographics: 
 During the study period, 100 vascular access procedures were undertaken 
on 74 patients (male 49) children and adolescents. Mean patient age at initial 
access formation was 12.35 years (range 8-16 years).  
Type of access:  
Seventy-two patients had creation of autogenous fistulas and only 2 had 
synthetic AVGs inserted in the forearm. Of 100 procedures undertaken, 51% 
were radiocephalic fistulas, 37% were brachiocephalic fistulas and 8% were 
brachiobasilic transpositions. One patient had transposition of GSV and 
anastomosis from brachial artery to axillary vein. Fifty three patients 
(71.6%)underwent a solitary vascular access procedure. 
The only two patients who had insertion of AVGs were females (16 and 
18 years old) who had a synthetic graft placed in the forearm from brachial 
artery to axillary vein. 
Primary success/ failure: 
 Primary access failure occurred in 22 of 100 procedures (22%). 
Thereafter, four fistulas failed over the study period. 
 In the analysis of factors and their potential correlation to the primary 
result, only age at onset of CKD was found to be statistically significant. Age 
and weight of the patient at the time of creation of vascular access was not 
related to the success of the procedure. However, the results also show that 
patients with age <10 years were maintained on catheter based haemodialysis  
in ICH and these patients were  not referred for the creation of AVF. Even 
weight did not have a correlation to the primary result. 
 Figures 20 and 21 are Kaplan Meier curves showing the actuarial survival 
of the vascular access. They show that radiocephalic and brachiocephalic 
fistulas have better patency than brachiobasilic fistulas. 
Complications and interventions: 
 Eighty-one procedures were uneventful. Ten patients developed edema 
and/or seroma formation which resolved with conservative management. One 
patient had infection of the wound following superficialization of a 
brachiobasilic fistula. One patient developed a pseudoaneurysm of the left 
radiocephalic fistula which required ligation of the left radial artery. 
 One patient developed steal symptoms of left upper limb after creation of 
an AVG which resolved with conservative management. Two patients had 
minor oozing from the wound which required opening of a few sutures to let out 
the haematoma and frequent dressing changes for 1 day. 
 One patient developed thrombosis of the right brachial artery and 
disappearance of thrill after a brachiocephalic fistula. He underwent exploration 
of wound, thrombectomy of the brachial artery and redo brachiocephalic fistula 
after 2 days. Thereafter, the fistula was functional. 
 One patient developed thrombosis of the AVG and required graft 
thrombectomy after which it was functional till she was lost to follow-up. 
 Seven patients died due to complications of renal failure. 
Discussion of results: 
 Choice of vascular access in children is often dictated by their size and 
age. In ICH, over a month period, all patients under 10 years of age underwent 
HD by CVC, either through IJV, subclavian or femoral catheter. However, 76% 
of the dialyses in children aged 10-15 years was done through an AVF. 
Creation of permanent vascular access in children maybe technically 
more difficult; however, reliable access can be achieved in even small children 
weighing as less as 15kgs. Even though p value was not statistically significant, 
we still fell that the most important factor is the use of magnification (surgical 
loupes) and meticulous care during vessel handling.  
 In this study, the majority of patients underwent autologous fistula 
creation which supports the theme of the Paediatric Fistula First Initiative. 
However, only 24% of these were created pre-emptively, rest were on dialysis 
either through PD or CVC.  
 In our study, there was primary failure rate of 22% which is consistent 
with the figures quoted in international studies on paediatric vascular access 
procedures.  
 
  
Photographs: 
 
Photo 1. Intraoperative photograph showing that part of the anastomosis has been completed. A is the anastomosis. 
 
Photo 2.  Intraoperative photograph showing the completed anastomosis. 
 Photo 3. Intraoperative photograph showing the array of microsurgical instruments used. 
 
Photo 4. A boy with ESRD receiving haemodialysis via his right brachiocephalic fistula. 
 Photo 5. Dialysis details of the above boy. 
 
 
Photo 6. Boy with ESRD receiving haemodialysis via left brachiocephalic fistula 
 
 Photo 6.  Dialysis settings 
 
Photo 7. Cannula used to access the AVF. 
 Photo 8. Intraoperative photograph showing the completed anastomosis - radiocephalic fistula. 
 
Photo 9. Photograph showing previous failed AVFs in a boy who underwent left radiocephalic fistula. 
 Photo 10.  Postoperative photograph showing a two-stage brachiobasilic transposition right arm. 
 Photo 11. Collage of photographs of children with ESRD with a successful creation of AVF. 
  
Conclusions: 
An arteriovenous fistula is the optimal vascular access in children 
undergoing haemodialysis. With the Paediatric Fistula First Initiative, various 
centres worldwide have started using microsurgical techniques to create fistulas 
and use it as the primary vascular access with good results even in small 
children. The various advantages of using an AVF as the primary access in 
children includes its long life, low rate of complications and lower overall costs, 
albeit it has a higher primary failure rate than CVCs or AVGs.  
This study shows how even in resource-challenged countries, children 
with ESRD can be successfully managed on long term haemodialysis with 
AVF. These children tend to have less complications and hospitalizations 
compared to their counterparts who have CVCs for long durations.  
These results show that even in countries with limited resources, it is 
possible to reach and even surpass the KDOQI recommended target of 50% 
AVF use as primary access choice in children with ESRD. The communication 
between the surgeon, pediatric nephrologist and the dialysis technician/staff is 
integral in determining time to first use and proper cannulation technique to 
ensure adequate use for dialysis. We have confirmed what others have shown; 
that AVF can be successfully used in paediatric HD patients with careful 
diagnostic evaluation, optimal access site selection, meticulous microsurgical 
technique and multidisciplinary management of the access. Based on our 
results, we would advocate paediatric dialysis centres to work in collaboration 
with a vascular surgeon who is versed in these techniques to create a 
functioning AVF. 
 
 
 
  
Limitations: 
Even though this study was undertaken as a prospective cohort analysis, 
follow-up was inadequate. When the children came, it was usually for a failed 
fistula requiring creation of a new one. It is difficult to calculate how many 
children succumbed to their disease.  
Moreover, measures to check dialysis adequacy were not reliable and 
varied from centre to centre. Therefore, this was not included as part of study. 
 
 
 
Implications for further research: 
Health related quality of life studies can be performed in these patients and their 
parents/caregivers to understand the significance of the impact of the disease 
and the various treatment modalities (CVC, PD vs HD) have on their daily life. 
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